Prognostic importance of low c-erbB2 expression in breast tumors

被引：6

作者：

Ferrero-Poüs, M ^{[1
]}

Hacène, K ^{[1
]}

Tubiana-Hulin, M ^{[1
]}

Spyratos, F ^{[1
]}

机构：

[1] Ctr Rene Huguenin, Lab Oncobiol, F-92211 St Cloud, France

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1999年 / 91卷 / 18期

关键词：

D O I：

10.1093/jnci/91.18.1584

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1584 / 1585

页数：2

共 5 条

[1] Prognostic value of urokinase plasminogen activator in primary breast carcinoma:: comparison of two immunoassay methods [J].

Bouchet, C ;

Spyratos, F ;

Hacène, K ;

Durcos, L ;

Bécette, V ;

Oglobine, J .

BRITISH JOURNAL OF CANCER, 1998, 77 (09) :1495-1501

[2]

Dittadi R, 1997, ANTICANCER RES, V17, P1245

[3] Prognostic importance of low c-erbB2 expression in breast tumors [J].

Koscielny, S ;

Terrier, P ;

Spielmann, M ;

Delarue, JC .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (09) :712-712

[4] Quantitative determination of c-erbB-2 in human breast tumours: Potential prognostic significance of low values [J].

Koscielny, S ;

Terrier, P ;

Daver, A ;

Wafflart, J ;

Goussard, J ;

Ricolleau, G ;

Delvincourt, C ;

Delarue, JC .

EUROPEAN JOURNAL OF CANCER, 1998, 34 (04) :476-481

[5] The HER-2/neu oncogene in breast cancer: Prognostic factor, predictive factor, and target for therapy [J].

Ross, JS ;

Fletcher, JA .

STEM CELLS, 1998, 16 (06) :413-428

← 1 →